Cliff Asness's TERN Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 176,773 shares of Terns Pharmaceuticals, Inc. (TERN) worth $9.32 M, representing 0.00% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in TERN, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 130,449 shares. Largest reduction occurred in Q4 2023, reducing 17,014 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Terns Pharmaceuticals (TERN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Terns Pharmaceuticals (TERN) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +130,449 | Add 281.60% | 176,773 | $52.72 |
| Q4 2025 | +6,140 | Add 15.28% | 46,324 | $40.40 |
| Q3 2025 | +3,210 | Add 8.68% | 40,184 | $7.51 |
| Q2 2025 | +36,974 | New Buy | 36,974 | $3.73 |
| Q1 2025 | -16,868 | Sold Out | 0 | $0.00 |
| Q4 2024 | +16,868 | New Buy | 16,868 | $5.54 |
| Q4 2023 | -17,014 | Sold Out | 0 | $0.00 |
| Q3 2023 | -1,049 | Reduce 5.81% | 17,014 | $5.03 |
| Q2 2023 | +18,063 | New Buy | 18,063 | $8.75 |
Cliff Asness's Terns Pharmaceuticals Investment FAQs
Cliff Asness first purchased Terns Pharmaceuticals, Inc. (TERN) in Q2 2023, acquiring 18,063 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Terns Pharmaceuticals, Inc. (TERN) for 9 quarters since Q2 2023.
Cliff Asness's largest addition to Terns Pharmaceuticals, Inc. (TERN) was in Q1 2026, adding 176,773 shares worth $9.32 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 176,773 shares of Terns Pharmaceuticals, Inc. (TERN), valued at approximately $9.32 M.
As of the Q1 2026 filing, Terns Pharmaceuticals, Inc. (TERN) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Terns Pharmaceuticals, Inc. (TERN) was 176,773 shares, as reported at the end of Q1 2026.